Newsletter | April 2026

Apply Now: 2027 Fellowships and Grants

Drug Discovery and Drug Delivery Deadline in One Week:
April 15 @ 12:00 p.m. (Noon) ET

This program funds novel, early-stage, drug discovery research with a clear potential for translation to humans.

This program funds research that optimizes drug composition, dosage, and delivery to make treatments clinically viable, safer, more effective, and/or easier to manage for patients.

This program funds research that identifies unmet clinical needs and develops new diagnostic, therapeutic, and computational approaches and technologies to improve patient care.


The Translational Medicine application portal opens April 15.

Letter of Intent Deadline: May 27 @ 12:00 p.m. (Noon) ET

Submit a Paper: $5k Trainee Challenge Award

The PhRMA Foundation (PhF) and the journal Pharmaceutical Research are partnering on a Challenge Award competition to recognize trainee researchers for outstanding manuscripts in a special collection on “Advancing Genetic Medicine: Discovery, Development, and Delivery.”


The PhRMA Foundation will provide the Challenge Award — a prize of $5,000 — to the first author of up to five winning papers, and Pharmaceutical Research will publish the accepted manuscripts as part of a special collection.


Deadline: June 1, 2026

PhF Expands 2026 Awards With Industry Support, Reaching 65 Early-Career Researchers

The PhRMA Foundation awarded 65 early-career researchers more than $4.6 million in 2026 fellowships and grants — up from 41 awardees in 2025. This expansion was made possible by generous donations from pharmaceutical companies that support our work.

The Importance of Funding Early-Career Researchers

In this video, PhRMA Foundation award recipients describe what the Foundation's support means to them.


For 60 years, the PhRMA Foundation has funded early-career researchers, helping to build and train the scientific workforce.

Meet the Researchers

Hear our awardees discuss their research projects and career paths in videos and blogs.

Gracelyn Richmond: Designing a ‘Superhero Bacteria’ to Relieve Gut Stress

Dr. Mark Milner: A Philosophy of ‘Good People, Good Science’

Isakadze-Nino_DHT25_hearts2-e1771346853712-536x401-c-default image

Dr. Nino Isakadze: Using Digital Health Tools and AI to Improve Outcomes for Patients with Irregular Heartbeat

2025 Annual Report

In 2025, the PhRMA Foundation celebrated 60 years of supporting early career researchers and tackling topics important to industry through research funding opportunities.


The Foundation’s 2025 Annual Report highlights more than 40 promising scientists who received our funding for their research in the areas of drug discovery, drug delivery, translational medicine, and value assessment and health outcomes research.


Awardee Publications

Congrats to these Foundation-funded researchers on their recent work.

**Indicates research directly supported by a PhRMA Foundation award.

**SmartBoot: Real-Time Monitoring of Patient Activity via Remote Edge Computing Technologies, Sensors

David G. Armstrong, DPM, MD, PhD (PhF24), University of Southern California

**AI-Guided Remission: Protocol for a Conversational Agent (Chatbot) for Dosing Activity and Footwear Progression After Diabetic Limb Reconstruction, Sensors

David G. Armstrong, DPM, MD, PhD (PhF24), University of Southern California

**Mechanistic insights into the therapeutic properties of delta opioid receptor, Science Advances

Sarah Bernhard, PhD (PhF23), Washington University in St. Louis

**Colistin-stabilized antisolvent precipitation enables engineering of microcrystalline niclosamide for inhalable composite powders, International Journal of Pharmaceutics

Ashlee Brunaugh, PharmD, PhD (PhF23), University of Michigan

**IFNγ-induced antigen loss in chimeric antigen receptor-T cell therapy, Frontiers in Immunology

Miao Cao (PhF25), Thomas Jefferson University

Patient-Reported Outcome Measures in Clinical Trials: An Analysis of Trends From 2008 to 2023, Value in Health

Maja Kuharic, MPharm, MSc, PhD (PhF25), Northwestern University

**Comparative in vitro activity of aztreonam–avibactam and aztreonam plus ceftazidime–avibactam against Stenotrophomonas maltophilia complex, Antimicrobial Agents and Chemotherapy

Ashlan J. Kunz Coyne, PhD (PhF25), University of Kentucky

Rational design and in vivo validation of capsid inhibitors for enterovirus D68, Nature Communications

Kan Li (PhF26), Rutgers University

Rational Design of Capsid Protein VP1 Degraders to Overcome Pleconaril Resistance in Inhibiting Enterovirus D68, JACS Au

Kan Li (PhF26), Rutgers University

Bridging the knowledge gap: Med Wise Rx helps older adults navigate comprehensive medication reviews, Journal of the American Pharmacists Association

Helen Omuya, MPA, PhD (PhF23), University of Alabama at Birmingham

A Health Equity Study of Heart Health Promotion in Black Adults: Cultural Strengths and Heart Health Behaviors, Journal of Transcultural Nursing

Helen Omuya, MPA, PhD (PhF23), University of Alabama at Birmingham

Promoting knowledge transfer: A RE-AIM evaluation of a VA Healthcare System's success strategies in improving patient safety through deprescribing, Journal of the American Pharmacists Association

Helen Omuya, MPA, PhD (PhF23), University of Alabama at Birmingham

**Concomitant COX-1 and COX-2 suppression is not sufficient to induce enteropathy associated with chronic NSAID use, Journal of Clinical Investigation

Emanuela Ricciotti, PharmD, PhD (PhF16), University of Pennsylvania

**Supramolecular coiled-coil peptide platform for site-specific antibody drug conjugate engineering, Nature Communications

Alina Ringaci (PhF25), Boston University

Wearable Sleep Measures May Improve Machine Learning Prediction of Home-Based Pulmonary Rehabilitation Engagement Among Patients With Chronic Obstructive Pulmonary Disease: A Proof-of-Concept Study, Mayo Clinic Proceedings: Digital Health

Stephanie Zawada, MS, PhD (PhF23), Mayo Clinic

Awardee News

Masuda Akther, MS (PhF26) recently presented her PhF-funded work at a New York Academy of Sciences' symposium on Cancer Metabolism and Signaling in the Tumor Microenvironment.

David G. Armstrong, DPM, MD, PhD (PhF24) of the University of Southern California and his team have created a series of data visualizations to raise awareness about the amputation crisis. The ZIP Code Lottery shows how amputation rates across Los Angeles County track almost perfectly with ZIP code and poverty, not clinical severity, while the Amputation Heat Map shows the disproportionate amputation rates across the nation. The Global Limb Threat Index shows how amputation rates track with systems of care, not disease biology alone.

Samagya Banskota, PhD (PhF25) of Boston University recently received a Maximizing Investigators' Research Award (MIRA) R35 grant from the National Institute of General Medical Sciences.

Sarah Bernhard, PhD (PhF23) will start a postdoctoral position May 1 at ETH Zurich, supported by the ETH Zurich Postdoctoral Fellowship Award.

Indrani Das (PhF26) of Case Western Reserve University won a Young Investigator Award from the American Academy of Immunologists in February, when she presented her PhF-funded work at the Translation Research Cancer Centers Consortium.

Claire Fleming, MS (PhF25) of the University of Virginia received the Best Oral Presentation by a Student award at the Lorne Infection and Immunity Conference in February.

Maja Kuharic, MPharm, MSc, PhD (PhF25) of Northwestern University presented her PhF-funded preliminary research findings on care recipient self-perceived burden as an invited speaker at the University of Chicago Chronic Disease Seminar Series. She also received third place in the 2025 Outstanding Articles of the Year award from the journal Quality of Life Research and delivered a short course at the ISPOR United Arab Emirates Chapter Conference.

Ariel Leyte-Vidal (PhF25) received the award for Best Research Poster Presentation at the Biochemistry and Molecular Biology Research Day at the University of Miami for her PhF-funded project.

Helen Omuya, MPA, PhD (PhF23) recently began as an assistant professor at the University of Alabama at Birmingham.

SonikaKohli1 image

Ritu Raman, PhD (PhF22) and her lab at the Massachusetts Institute of Technology won the Koch Institute Image Award for their art piece titled “Repairing Lost Connections,” featuring the lab’s work on treating nerve injuries.

Wei “Adelyn” Tsai (PhF25) of Mayo Clinic will give an oral presentation at 2026 AD/PD conference in Copenhagen, Denmark, for her project titled "Cell type specific gene expression changes are associated with cerebral amyloid angiopathy and blood-brain barrier integrity in Alzheimer’s disease."

Stephanie Zawada, MS, PhD (PhF23) of Mayo Clinic received news coverage in Becker's Hospital Review of her recent research validating methods from her PhF study in a serious illness (COPD) cohort. She will also be a speaker on wearables in safety-net populations at AcademyHealth's Health IT Group in Seattle in May.

Did someone forward this to you?

Subscribe to get updates and funding announcements directly in your inbox.

LinkedIn  Twitter  YouTube

www.phrmafoundation.org